,25 Hence, we hypothesized that designing PD-L1 targeting CAR T cells would not only be able to strike tumor cells but would also attack the PD-L1-expressing regulatory/support cells, resulting in the destabilization of the cellular network that generates the immunosuppressive TME. This evidence concerns the gene CD274 and neoplasm.